Risk of arteriovenous fistula failure associated with hypnotic use in hemodialysis patients: a nested case-control study

Pharmacoepidemiology and Drug Safety
Chao-Feng LinLi-Nien Chien

Abstract

Hypnotic use might cause altered inflammatory processes, which have been suggested as being related to the mechanisms of arteriovenous fistula (AVF) failure. Therefore, we examined the association between the risk of AVF failure and hypnotic use in patients receiving hemodialysis (HD). A nested case-control study was conducted using data from the National Health Insurance Research Database of Taiwan. From 34 165 HD patients, 3676 patients receiving percutaneous transluminal angioplasty or surgical thrombectomy for AVF failure were matched to 14 704 control patients according to sex, age (±1 year), and the year of initial HD therapy. The risk of AVF failure was estimated based on conditional logistic regression after adjustment for the timing of AVF creation, HD frequency, comorbidities, and prescribed medications. Hypnotic use was measured prior to the date of AVF failure of case patients and the date of pseudo-AVF failure of controls. Compared with matched controls, case patients were more likely to be exposed to hypnotics 30 days or an average daily defined dose > 0.5 within 90 days before the date of AVF failure, with an adjusted odds ratio of 1.21 (95% confidence interval [CI]: 1.09-1.35, p < 0.001) and 1.36 (95%CI: 1.13-1....Continue Reading

References

May 7, 1999·Kidney International·S J SchwabD Beasley
Apr 28, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M F WeissJ M Anderson
May 31, 2001·Kidney International·P Roy-ChaudhuryS C Heffelfinger
Oct 5, 2002·The Journal of Clinical Psychiatry·Maurice M Ohayon, Malcolm H Lader
Dec 3, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Rajiv SaranUNKNOWN Dialysis Outcomes and Practice Patterns Study
Dec 11, 2002·Kidney International·Hugh C RaynerUNKNOWN Dialysis Outcomes and Practice Patterns Study
Feb 25, 2003·Blood Purification·Prabir Roy-ChaudhurySue C Heffelfinger
Apr 12, 2003·Journal of Psychopharmacology·I A LiappasG N Christodoulou
Oct 29, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·George O TingShahrzad Zarghamee
Dec 13, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hugh C RaynerFriedrich K Port
Jan 9, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Chi-Jen ChangJong-Hwei S Pang
Oct 11, 2005·Molecular Immunology·Sabina AlamAdrian J Wolstenholme
Mar 28, 2006·Journal of the American Society of Nephrology : JASN·Prabir Roy-ChaudhuryAlfred K Cheung
Jul 4, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·UNKNOWN Vascular Access 2006 Work Group
Jan 4, 2007·Advances in Chronic Kidney Disease·Fliss E M MurtaghIrene J Higginson
Apr 7, 2007·Psychiatric Services : a Journal of the American Psychiatric Association·I-Chia ChienPesus Chou
Apr 24, 2007·The Lancet Infectious Diseases·Marius TerblancheDaniel G Hackam
Aug 28, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Troy J PlumbBryce Lund
Sep 14, 2007·Kidney International·W C WinkelmayerP S Wang
Feb 8, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Henricus J T HuijbregtsUNKNOWN CIMINO study group
Apr 17, 2008·Southern Medical Journal·Ghazi R QasaimehMariam Al Badadweh
Sep 17, 2008·American Journal of Epidemiology·Mirjam J KnolMatthias Egger
Nov 1, 2008·Annals of Vascular Surgery·Marco RighettiAdalberto Tommasi
Jul 7, 2009·Critical Care Clinics·Robert D SandersMervyn Maze
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Roopa BhatLawrence Steinman
May 29, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Roberto PisoniMichael Allo
Jun 26, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Mauricio Monroy-CuadrosChristopher Doig
Sep 16, 2010·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Geneviève Belleville
Nov 13, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Ahraaz WyneRita S Suri
Nov 26, 2010·The New England Journal of Medicine·Glenn M ChertowAlan S Kliger
Mar 1, 2012·BMJ Open·Daniel F KripkeLawrence E Kline
May 15, 2012·The Journal of Clinical Psychiatry·Chia-Hung KaoJi-An Liang
Jun 26, 2012·Journal of Vascular Surgery·Jun-Neng RoanChen-Fuh Lam
Jul 14, 2012·Critical Care : the Official Journal of the Critical Care Forum·Anders Gunnar NielsenReimar Wernich Thomsen
Mar 13, 2013·Critical Care Medicine·Robert D SandersTracy Hussell
Apr 6, 2013·BMC Nephrology·Gürbey OcakMarion Verduijn
May 3, 2013·Kidney International·Rajiv JanardhananSanjay Misra
Aug 28, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Steven M ShechterNadia Zalunardo
Nov 16, 2013·Psychiatric Services : a Journal of the American Psychiatric Association·Liang-Jen WangMiao-Chun Chou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved